RareCan is an organisation for the purpose of speeding up research and ultimately improving outcomes for people with rarer forms of cancer.
RareCan has raised $456K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in June 2022.
RareCan's investors include Crowdcube, Mandashi, Innovation SuperNetwork.
RareCan is headquartered in Hexham, United Kingdom.
RareCan is an organisation for the purpose of speeding up research and ultimately improving outcomes for people with rarer forms of cancer.
RareCan is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RareCan — Funding & Investors." VCBacked, June 15, 2022, https://www.vcbacked.co/company/rarecan. Accessed August 14, 2026.
VCBacked. (2022). RareCan — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/rarecan
{{cite web |title=RareCan — Funding & Investors |url=https://www.vcbacked.co/company/rarecan |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated